Gina Collins - Jul 17, 2024 Form 3 Insider Report for Trulieve Cannabis Corp. (TRUL)

Role
Chief Marketing Officer
Signature
/s/Gina Collins
Stock symbol
TRUL
Transactions as of
Jul 17, 2024
Transactions value $
$0
Form type
3
Date filed
11/21/2024, 05:40 PM
Previous filing
Oct 26, 2023
Next filing
Nov 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TRUL Subordinate Voting Shares 103K Jul 17, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TRUL Stock Option (Right to Buy) Jul 17, 2024 Subordinate Voting Shares 24.9K $21.48 Direct F2
holding TRUL Stock Option (Right to Buy) Jul 17, 2024 Subordinate Voting Shares 128K $3.99 Direct F3
holding TRUL Stock Option (Right to Buy) Jul 17, 2024 Subordinate Voting Shares 67.9K $10.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount of securities beneficially owned in column 2 includes several grants of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. The reporting person: (i) was granted 8,729 RSUs on February 24, 2022, subject to 2-year vesting; the RSUs vested 50% on December 29, 2023 and will vest 50% on December 29, 2024; (ii) was granted 57,515 RSUs on July 25, 2023, subject to 2-year vesting; the RSUs will vest 50% on December 1, 2024 and 50% on December 1, 2025; and (iii) was granted 37,500 RSUs on March 8, 2024, subject to 2-year vesting; the RSUs will vest 50% on December 1, 2025 and 50% on December 1, 2026.
F2 The options were granted on February 24, 2022, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on each of December 1, 2022; and December 1, 2023; one third of the options will vest and become exercisable on December 1, 2024.
F3 The options were granted on July 25, 2023, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on December 1, 2023; one third of the options will vest and become exercisable on December 1, 2024, and one third of the options will vest and become exercisable on December 1, 2025.
F4 The options were granted on March 8, 2024, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options will vest and become exercisable on December 1, 2024, one third of the options will vest and become exercisable on December 1, 2025, and one third of the options will vest and become exercisable on December 1, 2026.